1a29
From Proteopedia
(New page: 200px<br /><applet load="1a29" size="450" color="white" frame="true" align="right" spinBox="true" caption="1a29, resolution 2.74Å" /> '''CALMODULIN COMPLEXED...) |
|||
Line 1: | Line 1: | ||
- | [[Image:1a29.gif|left|200px]]<br /><applet load="1a29" size=" | + | [[Image:1a29.gif|left|200px]]<br /><applet load="1a29" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1a29, resolution 2.74Å" /> | caption="1a29, resolution 2.74Å" /> | ||
'''CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)'''<br /> | '''CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)'''<br /> | ||
==Overview== | ==Overview== | ||
- | The modulatory action of Ca2+-calmodulin on multiple targets is inhibited | + | The modulatory action of Ca2+-calmodulin on multiple targets is inhibited by trifluoperazine, which competes with target proteins for calmodulin binding. The structure of calmodulin crystallized with two trifluoperazine molecules is determined by X-ray crystallography at 2.74 A resolution. The X-ray data together with the characteristic and distinct signals obtained by circular dichroism in solution allowed us to identify the binding domains as well as the order of the binding of two trifluoperazine molecules to calmodulin. Accordingly, the binding of trifluperazine to the C-terminal hydrophobic pocket is followed by the interaction of the second drug molecule with an interdomain site. Recently, we demonstrated that the two bisindole derivatives, vinblastine and KAR-2 [3"-(beta-chloroethyl)-2",4"-dioxo-3, 5"-spirooxazolidino-4-deacetoxyvinblastine], interact with calmodulin with comparable affinity; however, they display different functional effects [Orosz et al. (1997) British J. Pharmacol. 121, 955-962]. The structural basis responsible for these effects were investigated by circular dichroism and fluorescence spectroscopy. The data provide evidence that calmodulin can simultaneously accommodate trifluoperazine and KAR-2 as well as vinblastine and KAR-2, but not trifluoperazine and vinblastine. The combination of the binding and structural data suggests that distinct binding sites exist on calmodulin for vinblastine and KAR-2 which correspond, at least partly, to that of trifluoperazine at the C-terminal hydrophobic pocket and at an interdomain site, respectively. This structural arrangement can explain why these drugs display different anticalmodulin activities. Calmodulin complexed with melittin is also able to bind two trifluoperazine molecules, the binding of which appears to be cooperative. Results obtained with intact and proteolytically cleaved calmodulin reveal that the central linker region of the protein is indispensable for simultanous interactions with two molecules of either identical or different ligands. |
==About this Structure== | ==About this Structure== | ||
- | 1A29 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with CA and TFP as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | + | 1A29 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=CA:'>CA</scene> and <scene name='pdbligand=TFP:'>TFP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1A29 OCA]. |
==Reference== | ==Reference== | ||
Line 17: | Line 17: | ||
[[Category: Naray-Szabo, G.]] | [[Category: Naray-Szabo, G.]] | ||
[[Category: Ovadi, J.]] | [[Category: Ovadi, J.]] | ||
- | [[Category: Vertessy, B | + | [[Category: Vertessy, B G.]] |
[[Category: CA]] | [[Category: CA]] | ||
[[Category: TFP]] | [[Category: TFP]] | ||
[[Category: calcium-binding protein]] | [[Category: calcium-binding protein]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:40:01 2008'' |
Revision as of 09:40, 21 February 2008
|
CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)
Overview
The modulatory action of Ca2+-calmodulin on multiple targets is inhibited by trifluoperazine, which competes with target proteins for calmodulin binding. The structure of calmodulin crystallized with two trifluoperazine molecules is determined by X-ray crystallography at 2.74 A resolution. The X-ray data together with the characteristic and distinct signals obtained by circular dichroism in solution allowed us to identify the binding domains as well as the order of the binding of two trifluoperazine molecules to calmodulin. Accordingly, the binding of trifluperazine to the C-terminal hydrophobic pocket is followed by the interaction of the second drug molecule with an interdomain site. Recently, we demonstrated that the two bisindole derivatives, vinblastine and KAR-2 [3"-(beta-chloroethyl)-2",4"-dioxo-3, 5"-spirooxazolidino-4-deacetoxyvinblastine], interact with calmodulin with comparable affinity; however, they display different functional effects [Orosz et al. (1997) British J. Pharmacol. 121, 955-962]. The structural basis responsible for these effects were investigated by circular dichroism and fluorescence spectroscopy. The data provide evidence that calmodulin can simultaneously accommodate trifluoperazine and KAR-2 as well as vinblastine and KAR-2, but not trifluoperazine and vinblastine. The combination of the binding and structural data suggests that distinct binding sites exist on calmodulin for vinblastine and KAR-2 which correspond, at least partly, to that of trifluoperazine at the C-terminal hydrophobic pocket and at an interdomain site, respectively. This structural arrangement can explain why these drugs display different anticalmodulin activities. Calmodulin complexed with melittin is also able to bind two trifluoperazine molecules, the binding of which appears to be cooperative. Results obtained with intact and proteolytically cleaved calmodulin reveal that the central linker region of the protein is indispensable for simultanous interactions with two molecules of either identical or different ligands.
About this Structure
1A29 is a Single protein structure of sequence from Bos taurus with and as ligands. Full crystallographic information is available from OCA.
Reference
Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies., Vertessy BG, Harmat V, Bocskei Z, Naray-Szabo G, Orosz F, Ovadi J, Biochemistry. 1998 Nov 3;37(44):15300-10. PMID:9799490
Page seeded by OCA on Thu Feb 21 11:40:01 2008